ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
196.50
-1.00 (-0.51%)
Oct 16, 2026, 1:54 PM CST

ACRO Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,9424,0401,5642,4091,024939
Market Cap Growth
220.77%158.32%-35.07%135.16%9.09%-
Enterprise Value
13,0593,6001,0512,150691860
Last Close Price
194.5066.0025.2838.9419.6924.61

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
264.27105.6235.3647.1837.0743.02
PB Ratio
13.083.662.503.512.717.22
P/TBV Ratio
13.163.682.523.562.767.69

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
247.5394.1123.7542.1125.0139.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.010.030.030.030.10
Net Debt / Equity Ratio
-0.83-0.88-0.77-0.81-0.81-0.38
Net Debt / EBITDA Ratio
10.5011.838.3012.765.271.05
Net Debt / FCF Ratio
10.8315.656.548.066.391.03
Asset Turnover
0.060.040.060.090.100.12
Inventory Turnover
1.371.691.791.091.050.52
Quick Ratio
60.4849.9027.5839.6625.826.11
Current Ratio
62.2851.1228.6841.0427.689.01
Return on Equity (ROE)
-9.57%-9.55%-9.46%-7.78%-23.94%-32.92%
Return on Assets (ROA)
-6.84%-6.45%-5.89%-5.46%-14.27%-18.87%
Return on Capital Employed (ROCE)
-8.60%-8.30%-10.20%-6.90%-16.30%-38.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.57%-2.05%-3.97%-1.72%-5.94%-5.41%
FCF Yield
-0.58%-1.53%-4.73%-2.88%-4.67%-5.13%
Buyback Yield / Dilution
-8.21%-0.04%-16.17%-11.22%-33.71%-17.22%